Shares of AXT Inc. (AXTI) snapped back sharply on Thursday, climbing 10.5% to $127.08 after Wednesday's bruising 5.7% selloff to $114.98 — a swing that unfolded without a single new earnings release, contract announcement, or analyst upgrade to explain it. AXT Surges 10.5% on Pure Momentum — But Can a Technical Bounce Justify a $127 Stock With No New News?

Shares of AXT Inc. whipped higher Thursday, jumping 10.5% to $127.08 after Wednesday's punishing 5.7% drop to $114.98 — all without a single fresh catalyst. With major U.S. indices down roughly 0.7–0.8% on the session, this is a stock-specific bounce, and investors need to understand what is — and isn't — underneath it.

  • A $8.6 Billion Company Still Losing Money

AXT's market cap now sits around $8.57 billion , yet trailing twelve-month revenue is just $88.32 million . That puts the forward price-to-earnings ratio at a staggering 370 and the price-to-sales ratio above 56 . The company still posted a net loss of $1.62 million last quarter . Today's bounce adds roughly $800 million in market value on zero new information — a vivid illustration of how momentum, not profit, is setting the price.

  • The AI Story Is Real, but the Stock Has Raced Far Past Analyst Targets

AXT's year-to-date surge of over 600% reflects its transition from a cyclical substrate supplier into an enabler of AI-driven optical infrastructure . Its indium phosphide order backlog exceeds $100 million , and management guided Q2 earnings per share of $0.06–$0.08, swinging from a projected loss to a profit . But the average 12-month analyst price target is just $87.75, with a high of $95 — meaning at $127, the stock trades 34% above the Street's most bullish case.

  • Leveraged ETFs and Thin Float Are Amplifying Every Swing

The launch of a 2x leveraged single-stock ETF tracking AXTI may be pulling more volume and speculative trading into the name, amplifying every headline . The recent $632.5 million equity offering already created sharp pullbacks on dilution fears, showing why disciplined traders treat AXTI as a trading vehicle, not a buy-and-hold position .

  • Export Permits Remain the Overlooked Risk

Chinese export control measures on indium and related products have affected permit timing, and the availability of these permits can influence AXT's ability to ship orders and impact revenue . Revenue already declined in Q4 2025 due to export permit delays, even as AI-driven demand surged . A regulatory hiccup could erase a bounce like today's overnight.

Bottom line: AXT's AI thesis has genuine backing — record backlog, improving margins, massive capacity investment. But a 10.5% dead-cat bounce on no news, in a stock already priced 45% above every analyst target, is a flashing signal that momentum, not fundamentals, is in the driver's seat.